Description
Recombinant monoclonal antibody to TAGLN. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the B-cell cDNA library SAIC-33B-129. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques.
Target
TAGLN
Target Alias Names
Transgelin, SM22, WS3-10
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression